1. Home
  2. ATS vs XENE Comparison

ATS vs XENE Comparison

Compare ATS & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATS Corporation

ATS

ATS Corporation

HOLD

Current Price

$30.99

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$41.53

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATS
XENE
Founded
1978
1996
Country
Canada
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.2B
IPO Year
2023
2014

Fundamental Metrics

Financial Performance
Metric
ATS
XENE
Price
$30.99
$41.53
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$35.00
$54.09
AVG Volume (30 Days)
183.5K
793.5K
Earning Date
02-04-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$2,048,319,324.00
$7,500,000.00
Revenue This Year
$16.92
N/A
Revenue Next Year
$5.13
N/A
P/E Ratio
$221.51
N/A
Revenue Growth
1.80
N/A
52 Week Low
$20.90
$26.74
52 Week High
$32.73
$46.60

Technical Indicators

Market Signals
Indicator
ATS
XENE
Relative Strength Index (RSI) 61.65 47.44
Support Level $30.21 $40.74
Resistance Level $31.83 $43.67
Average True Range (ATR) 1.20 1.53
MACD 0.16 0.09
Stochastic Oscillator 85.33 34.80

Price Performance

Historical Comparison
ATS
XENE

About ATS ATS Corporation

ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: